Parenteral Nutrition Market

Parenteral Nutrition Market (Type of Nutrition - Carbohydrates, Parenteral Lipid Emulsions, Single Dose Amino Acid Solutions, Trace Elements, Electrolytes and Minerals, Vitamins) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

  • Rep Id : TMRGL3611
  • Published On : Jan 2019
  • No. of Pages : 150
  • Category : Pharmaceutical

 

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Parenteral Nutrition Market

4. Market Overview
     4.1. Introduction
            4.1.1. By Type of Nutrition Introduction
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
     4.4. Global Parenteral Nutrition Market Analysis and Forecasts, 2016–2026
            4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook
     5.1. Clinical Trial Pipeline Analysis
     5.2. Key Mergers & Acquisitions
     5.3. Cancer Diseases Epidemiology Analysis, by Key Country/Region
     5.4. Inflammatory Bowel Diseases Epidemiology Analysis, by Key Country/Region
     5.5. Preterm Birth Epidemiology Analysis, by Key Country/Region

6. Global Parenteral Nutrition Market Analysis and Forecast, by Type of Nutrition 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Global Parenteral Nutrition Market Value Forecast, by Type of Nutrition, 2016–2026
            6.3.1. Carbohydrates
            6.3.2. Parenteral Lipid Emulsions
            6.3.3. Single Dose Amino Acid Solutions 
            6.3.4. Trace Elements, Electrolytes, & Minerals
            6.3.5. Vitamins
     6.4. Global Parenteral Nutrition Market Attractiveness, by Type of Nutrition

7. Global Parenteral Nutrition Market Analysis and Forecast, by Region
     7.1. Key Findings
     7.2. Global Parenteral Nutrition Market Value Forecast, by Region
            7.2.1. North America 
            7.2.2. Europe 
            7.2.3. Asia Pacific 
            7.2.4. Latin America 
            7.2.5. Middle East & Africa 
     7.3. Global Parenteral Nutrition Market Attractiveness, by Region

8. North America Parenteral Nutrition Market Analysis and Forecast
     8.1. Introduction
     8.1.1. Key Findings
     8.2. North America Parenteral Nutrition Market Value Forecast, by Type of Nutrition, 2016–2026
            8.2.1. Carbohydrates
            8.2.2. Parenteral Lipid Emulsions
            8.2.3. Single Dose Amino Acid Solutions 
            8.2.4. Trace Elements, Electrolytes, & Minerals
            8.2.5. Vitamins
     8.3. North America Parenteral Nutrition Market Value Forecast, by Country, 2016–2026
            8.3.1. U.S.
            8.3.2. Canada
     8.4. North America Parenteral Nutrition Market Attractiveness Analysis 
            8.4.1. By Type of Nutrition 
            8.4.2. By Country

9. Europe Parenteral Nutrition Market Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
     9.2. Europe Parenteral Nutrition Market Value Forecast, by Type of Nutrition, 2016–2026
            9.2.1. Carbohydrates
            9.2.2. Parenteral Lipid Emulsions
            9.2.3. Single Dose Amino Acid Solutions 
            9.2.4. Trace Elements, Electrolytes, & Minerals
            9.2.5. Vitamins
     9.3. Europe Parenteral Nutrition Market Value Forecast, by Country/Sub-region, 2016–2026
            9.3.1. Germany
            9.3.2. U.K.
            9.3.3. France
            9.3.4. Spain
            9.3.5. Italy
            9.3.6. Rest of Europe
     9.4. Europe Parenteral Nutrition Market Attractiveness Analysis 
            9.4.1. By Type of Nutrition 
            9.4.2. By Country/Sub-region

10. Asia Pacific Parenteral Nutrition Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. Asia Pacific Parenteral Nutrition Market Value Forecast, by Type of Nutrition, 2016–2026
            10.2.1. Carbohydrates
            10.2.2. Parenteral Lipid Emulsions
            10.2.3. Single Dose Amino Acid Solutions 
            10.2.4. Trace Elements, Electrolytes, & Minerals
            10.2.5. Vitamins
     10.3. Asia Pacific Parenteral Nutrition Market Value Forecast, by Country/Sub-region, 2016–2026
            10.3.1. China
            10.3.2. Japan
            10.3.3. India
            10.3.4. Australia & New Zealand
            10.3.5. Rest of Asia Pacific
     10.4. Asia Pacific Parenteral Nutrition Market Attractiveness Analysis 
            10.4.1. By Type of Nutrition 
            10.4.2. By Country/Sub-region

11. Latin America Parenteral Nutrition Market Analysis and Forecast
     11.1.Introduction
            11.1.1. Key Findings
     11.2. Latin America Parenteral Nutrition Market Value Forecast, by Type of Nutrition, 2016–2026
            11.2.1. Carbohydrates
            11.2.2. Parenteral Lipid Emulsions
            11.2.3. Single Dose Amino Acid Solutions 
            11.2.4. Trace Elements, Electrolytes, & Minerals
            11.2.5. Vitamins
     11.3. Latin America Parenteral Nutrition Market Value Forecast, by Country/Sub-region, 2016–2026
            11.3.1. Brazil
            11.3.2. Mexico
            11.3.3. Rest of Latin America
     11.4. Latin America Parenteral Nutrition Market Attractiveness Analysis 
            11.4.1. By Type of Nutrition 
            11.4.2. By Country/Sub-region

12. Middle East & Africa Parenteral Nutrition Market Analysis and Forecast
     12.1.Introduction
            12.1.1. Key Findings
     12.2. Middle East & Africa Parenteral Nutrition Market Value Forecast, by Type of Nutrition, 2016–2026
            12.2.1. Carbohydrates
            12.2.2. Parenteral Lipid Emulsions
            12.2.3. Single Dose Amino Acid Solutions 
            12.2.4. Trace Elements, Electrolytes, & Minerals
            12.2.5. Vitamins
     12.3. Middle East & Africa Parenteral Nutrition Market Value Forecast, by Country/Sub-region, 2016–2026
            12.3.1. GCC Countries
            12.3.2. South Africa
            12.3.3. Rest of Middle East & Africa
     12.4. Middle East & Africa Parenteral Nutrition Market Attractiveness Analysis 
            12.4.1. By Type of Nutrition 
            12.4.2. By Country/Sub-region

13. Competition Landscape
     13.1. Global Parenteral Nutrition Market Player – Competition Matrix (By Tier and Size of companies)
     13.2 Global Parenteral Nutrition Market Share Analysis, by Company (2017)
     13.3. Company Profiles
            13.3.1. B. Braun Melsungen AG
            13.3.2. Baxter International Inc.
            13.3.3. Fresenius Kabi AG
            13.3.4. Grifols, S.A.
            13.3.5. Pfizer, Inc. 
            13.3.6. Allergan plc
            13.3.7. Claris Life Sciences Ltd.
            13.3.8. Vifor Pharma Ltd.
            13.3.9. Sichuan KELUN PHARMACEUTICAL Co., Ltd

List of Tables

Table 01: Global Parenteral Nutrition Market Value (US$ Mn) Forecast, by Type of Nutrition, 2016–2026
Table 02: Global Parenteral Nutrition Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 03: North America Parenteral Nutrition Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 04: North America Parenteral Nutrition Value (US$ Mn) Forecast, by Type of Nutrition, 2016–2026
Table 05: Europe Parenteral Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 06: Europe Parenteral Nutrition Value (US$ Mn) Forecast, by Type of Nutrition, 2016–2026
Table 07: Asia Pacific Parenteral Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 08: Asia Pacific Parenteral Nutrition Value (US$ Mn) Forecast, by Type of Nutrition, 2016–2026
Table 09: Latin America Parenteral Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 10: Latin America Parenteral Nutrition Value (US$ Mn) Forecast, by Type of Nutrition, 2016–2026
Table 11: Middle East & Africa Parenteral Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Middle East & Africa Parenteral Nutrition Value (US$ Mn) Forecast, by Type of Nutrition, 2016–2026

List of Figures

Figure 01: Global Parenteral Nutrition Market Value (US$ Mn) Snapshot, by Type of Nutrition, 2017(A)
Figure 02: Global Parenteral Nutrition Market Snapshot
Figure 03: Global Parenteral Nutrition Market Share (%) Snapshot, by Region, 2017(A)
Figure 04: Global Parenteral Nutrition Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 05: Global Parenteral Nutrition Market, Opportunity Map, by Type of Nutrition
Figure 06: Global Parenteral Nutrition Market Value (US$ Mn) Forecast, 2016-2026
Figure 07: Global Parenteral Nutrition Market Value Share (%), by Type of Nutrition (2017)
Figure 08: Global Parenteral Nutrition Market Value Share (%), by Region (2017)
Figure 09: Global Parenteral Nutrition Market Clinical Trial Pipeline Analysis: Pfizer Inc.
Figure 10: Global Parenteral Nutrition Market Clinical Trial Pipeline Analysis: B. Braun Melsungen AG
Figure 11: Global Parenteral Nutrition Market Clinical Trial Pipeline Analysis: Fresenius Kabi AG 
Figure 12: Global Parenteral Nutrition Market Clinical Trial Pipeline Analysis: Baxter International Inc.
Figure 13: Global Parenteral Nutrition Market Clinical Trial Pipeline Analysis: Allergan plc.
Figure 14: Global Parenteral Nutrition Market Clinical Trial Pipeline Analysis: Claris Life Sciences Ltd.
Figure 15: Parenteral Nutrition Market: Mergers & Acquisitions
Figure 16: Summary of the Studies on the Prevalence of Non-melanoma skin cancer
Figure 17: Summary of the Studies on the Prevalence of Lung Cancer
Figure 18: Summary of the Studies on the Prevalence of Breast Cancer
Figure 19: Summary of the Studies on the Prevalence of Prostate Cancer
Figure 20: Summary of the Studies on the Prevalence of Colorectal Cancer
Figure 21: Prevalence Inflammatory Bowel Disease, by Key Countries (2016)
Figure 22: Global Preterm Birth Epidemiology Analysis, by Key Countries (2/3)
Figure 23: Global Preterm Birth Epidemiology Analysis, by Key Countries (2/2)
Figure 24: Global Parenteral Nutrition Market Value Share Analysis, by Type of Nutrition, 2017 and 2026
Figure 25: Global Parenteral Nutrition Market Attractiveness, by Type of Nutrition, 2018–2026
Figure 26: Global Parenteral Nutrition Market Value (US$ Mn) Forecast and Y-o-Y Growth (%)                  Projection, by Carbohydrates, 2016–2026
Figure 27: Global Parenteral Nutrition Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Parenteral Lipid Emulsions, 2016–2026
Figure 28: Global Parenteral Nutrition Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Single Dose Amino Acid Solutions, 2016–2026
Figure 29: Global Parenteral Nutrition Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Trace Elements, Electrolytes, & Minerals, 2016–2026
Figure 30: Global Parenteral Nutrition Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Vitamins, 2016–2026
Figure 31: Global Parenteral Nutrition Market Value Share Analysis, by Region 2017 and 2026
Figure 32: Global Parenteral Nutrition Market Attractiveness, by Region, 2018–2026
Figure 33: North America Parenteral Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 34: North America Parenteral Nutrition Market Value Share (%), by Country, 2017 and 2026
Figure 35: North America Parenteral Nutrition Market Attractiveness, by Country, 2018–2026
Figure 36: North America Parenteral Nutrition Market Value Share (%), by Type of Nutrition, 2017 and 2026
Figure 37: North America Parenteral Nutrition Market Attractiveness, by Type of Nutrition, 2018–2026
Figure 38: Europe Parenteral Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 39: Europe Parenteral Nutrition Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 40: Europe Parenteral Nutrition Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 41: Europe Parenteral Nutrition Market Value Share (%), by Type of Nutrition, 2017 and 2026
Figure 42: Europe Parenteral Nutrition Market Attractiveness, by Type of Nutrition, 2018–2026
Figure 43: Asia Pacific Parenteral Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 44: Asia Pacific Parenteral Nutrition Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 45: Asia Pacific Parenteral Nutrition Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 46: Asia Pacific Parenteral Nutrition Market Value Share (%), by Type of Nutrition, 2017 and 2026
Figure 47: Asia Pacific Parenteral Nutrition Market Attractiveness, by Type of Nutrition, 2018–2026
Figure 48: Latin America Parenteral Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 49: Latin America Parenteral Nutrition Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 50: Latin America Parenteral Nutrition Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 51: Latin America Parenteral Nutrition Market Value Share (%), by Type of Nutrition, 2017 and 2026
Figure 52: Latin America Parenteral Nutrition Market Attractiveness, by Type of Nutrition, 2018–2026
Figure 53: Middle East & Africa Parenteral Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 54: Middle East & Africa Parenteral Nutrition Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 55: Middle East & Africa Parenteral Nutrition Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 56: Middle East & Africa Parenteral Nutrition Market Value Share (%), by Type of Nutrition, 2017 and 2026
Figure 57: Middle East & Africa Parenteral Nutrition Market Attractiveness, by Type of Nutrition, 2018–2026
Figure 58: Global Parenteral Nutrition Market Share Analysis, by Company (2017)
Figure 59: B. Braun Melsungen AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 60: B. Braun Melsungen AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 61: B. Braun Melsungen AG Breakdown of Net Sales, by Business Segment, 2017
Figure 62: B. Braun Melsungen AG Breakdown of Net Sales, by Region, 2017
Figure 63: Baxter Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 64: Baxter R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 65: Baxter Breakdown of Net Sales, by Region, 2017
Figure 66: Baxter Breakdown of Net Sales (%), by Business Segment, 2017
Figure 67: Fresenius Kabi AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 68: Fresenius Kabi AG Breakdown of Net Sales, by Region, 2017
Figure 69: Fresenius Kabi AG Breakdown of Net Sales, by Segment, 2017
Figure 70: Fresenius Kabi AG Research & Development Cost, 2016 - 2017 (US$ Mn)
Figure 71: Grifols, S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 72: Grifols, S.A. Breakdown of Net Sales (%), by Business Segment, 2017
Figure 73: Grifols, S.A. Breakdown of Net Sales (%), by Region, 2016
Figure 74: Pfizer’s Breakdown of Net Sales, by Region, 2017
Figure 75: Pfizer's R&D Intensity and Sales & Marketing Intensity, 2016–2017
Figure 76: Allergan’s Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2017
Figure 77: Allergan’s Breakdown of Net Sales, by Business Segment (2017)
Figure 78: Allergan’s R&D Intensity and Sales & Marketing Intensity – Company Level, 2016–2017
Figure 79: Claris Life Sciences Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2017
Figure 80: Claris Life Sciences Revenue Breakdown of Net Sales, by Business Segment (2017)
Figure 81: Claris Life Sciences Revenue R&D Intensity and Sales & Marketing Intensity – Company Level, 2016–2017
Figure 82: Vifor Pharma Ltd. Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2017
Figure 83: Vifor Pharma Ltd. Revenue Breakdown of Net Sales, by Business Segment (2017)
Figure 84: Vifor Pharma Ltd. Revenue R&D Intensity and Sales & Marketing Intensity – Company Level, 2016–2017
Figure 85: Pfizer’s Breakdown of Net Sales, by Region, 2017
Figure 86: Vifor Pharma Ltd. Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2017
Figure 87: Vifor Pharma Ltd. Revenue Breakdown of Net Sales, by Business Segment (2017)
Figure 88: Pfizer’s Breakdown of Net Sales, by Region, 2017
Figure 89: Vifor Pharma Ltd. Revenue R&D Intensity and Sales & Marketing Intensity – Company Level, 2016–2017

.